Two Companies Launch IPOs in Nepal: Snow Rivers and Sopan Pharmaceuticals Open Issues

Two companies—Snow Rivers Limited and Sopan Pharmaceuticals Limited—have opened their initial public offerings (IPOs) simultaneously from Chaitra 09, signaling continued momentum in Nepal’s primary market.

Snow Rivers Limited has structured its IPO to include both project-affected locals and Nepalese citizens working abroad. The company has allocated 937,500 shares for locals and 93,750 shares for foreign-employed Nepalis. Within the local category, 468,750 shares have been earmarked for residents of Sirijangha-8 in Taplejung District, while an equal number has been set aside for other affected areas.

Applicants are required to apply for a minimum of 10 shares. Project-affected locals can apply for up to 10,000 shares, while foreign-employed Nepalis have a maximum application limit of 1,000 shares.

Foreign-employed Nepalis can apply through the C-ASBA system, while local applicants can submit applications via multiple collection centers, including Sanima Capital in Naxal, the project site in Yamphudin (Sirijangha-8), Nepal Bank branches, NMB Bank, Sanima Bank, and Global IME Bank in Taplejung.

The subscription period for locals is set from Chaitra 23 to Baishakh 08, while for foreign-employed Nepalis, the application window runs from Chaitra 12 to Chaitra 23. Sanima Capital Limited has been appointed as the issue manager for the offering.

Meanwhile, Sopan Pharmaceuticals Limited has issued 429,000 shares exclusively for Nepalese citizens working abroad who have obtained labor approval. Investors in this category can apply for a minimum of 10 shares and up to 11,000 shares, with the application deadline set for Chaitra 12.

In a subsequent phase, the company plans to issue 3,474,900 shares to the general public. NMB Capital Limited has been designated as the issue manager for Sopan Pharmaceuticals’ IPO.